BTMD - NASDAQ

biote Corp.

BTMD·NASDAQ

$2.11

+5.5%

HealthcareMedical - Care Facilities

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$93.07M

EPS0.8600

P/E Ratio2.45

Earnings Date08/05/2026

btmd

Total Stockholders' Equity

Last Annual Value

-58.54M

3-Year CAGR

-10%

5-Year CAGR

-28%

10-Year CAGR

-6%

Adjust for Inflation

biote Corp. Competitors Analysis of Total Stockholders' Equity

BTMD · NASDAQ

Company	Total Stockholders' Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
biote Corp. NASDAQ:BTMD	-58.54M	N/A	N/A	N/A
Anika Therapeutics, Inc. NASDAQ:ANIK	143.47M	-12.2%	-13.0%	-4.3%
Vor Biopharma Inc. NASDAQ:VOR	-164.31M	N/A	N/A	N/A
Lucid Diagnostics Inc. NASDAQ:LUCD	10.94M	N/A	-27.5%	N/A
DocGo Inc. NASDAQ:DCGO	144.01M	-21.8%	-8.1%	N/A
Microbot Medical Inc. NASDAQ:MBOT	77.55M	158.3%	40.1%	46.6%
AVITA Medical, Inc. NASDAQ:RCEL	-16.65M	N/A	N/A	N/A
Rapid Micro Biosystems, Inc. NASDAQ:RPID	33.21M	-34.5%	-31.6%	N/A
LENSAR, Inc. NASDAQ:LNSR	-26.02M	N/A	N/A	N/A
Instil Bio, Inc. NASDAQ:TIL	113.87M	-20.4%	-27.2%	N/A
Spero Therapeutics, Inc. NASDAQ:SPRO	59.02M	-18.0%	-7.7%	19.2%

biote Corp. Fair Value Envelope

BTMD · NASDAQ

Our analysis suggests that BTMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.11, this represents a potential HIDDEN relative to our calculated worth for biote Corp..

HIDDEN

Intrinsic Value

Current Price: $2.11

Related Guides

Blog Categories

Continue your BTMD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.